Salmon talks acquisitions, Blackstone, the FDA, and why Medtronic is in diabetes for the long haul
June 17, 2021
•
0 Comment
Sean Salmon, Executive Vice President and President, Diabetes Operating Unit, says Medtronic’s diabetes unit is reinvigorated by acquisitions, new internally developed products and a partnership with a private equity giant. In this MedtronicTalks podcast episode, Salmon explains why the diabetes community is excited about Medtronic’s pipeline and what the company is doing to meet those higher expectations.
